Skip to content

Efficacy and Safety of an Energy-Restricted Low-Fat Diet, a Low-Carbohydrate High-Protein Diet, and a Cantonese Balanced Diet for Weight Loss in Overweight and Obese Patients with Coronary Heart Disease: A Single-Center, Parallel, Randomized Controlled Trial

Efficacy and Safety of an Energy-Restricted Low-Fat Diet, a Low-Carbohydrate High-Protein Diet, and a Cantonese Balanced Diet for Weight Loss in Overweight and Obese Patients with Coronary Heart Disease: A Single-Center, Parallel, Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122253
Enrollment
Unknown
Registered
2026-04-10
Start date
2024-03-21
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Group A:Energy-Restricted Low-Fat Diet
Group B:Low-Carbohydrate High-Protein Diet
Group C:Cantonese Balanced Diet

Sponsors

Guangdong Provincial People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Participants must meet all of the following criteria: 1. Age between 18 and 70 years. 2. Body mass index (BMI) >= 24 kg/m² and increased waist circumference (>= 90 cm for men or >= 85 cm for women). 3. Chronic stable coronary heart disease, defined as a history of myocardial infarction (>= 1 month prior to randomization), prior percutaneous coronary intervention, prior coronary artery bypass grafting (CABG), or angiographically confirmed multivessel coronary artery disease. 4. Willingness to lose weight through lifestyle interventions. 5. Residence in Guangdong Province with no plans to relocate or travel outside the province during the next year. 6. Ability and willingness to provide written informed consent.

Exclusion criteria

Exclusion criteria: Participants meeting any of the following criteria will be excluded: 1. Diagnosis of type 1 diabetes mellitus. 2. Left ventricular systolic dysfunction with left ventricular ejection fraction (LVEF) 120 U/L or ALT > 150 U/L); or self-reported history of chronic hepatitis B with positivity for hepatitis B surface antigen [HBsAg], hepatitis B e antigen [HBeAg], and hepatitis B core antibody [anti-HBc]; or active viral hepatitis. 6. Severe renal impairment (estimated glomerular filtration rate [eGFR] =5 kg within the past 3 months. 20. Unwillingness or inability to modify habitual dietary patterns, or presence of special dietary requirements (e.g., vegetarian diet). 21. A hous

Design outcomes

Primary

MeasureTime frame
weight;BMI;waist circumference;Waist-to-hip ratio;Waist-to-height ratio;

Countries

China

Contacts

Public ContactHe Xuyu

Guangdong Provincial People’s Hospital

hexuyu97@126.com+86 136 3227 3712

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026